Friday, August 3, 2018

This Week's #CannabisStocks Added to Investor Ideas; (Nasdaq: $TLRY) (CSE: $CSI.C, $ISH.C)


This Week's #CannabisStocks Added to Investor Ideas; (Nasdaq: $TLRY) (CSE: $CSI.C, $ISH.C)


Point Roberts, WA, Delta BC – August 3, 2018 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its cannabis /hemp stock directory for investors following the sector.

Investorideas.com tracks cannabis and hemp publicly traded companies on the TSX, TSX.V, CSE, OTC, NYSE, NASDAQ, ASX  and global stock exchanges and makes ongoing additions to its stock directories for its members.  Free previews of all directories are available to the public with full login access only accessible to members.


This week’s additions include companies involved in research, production, cultivation, manufacture and distribution of medical and recreational cannabis and cannabinoids.

Investorideas.com cannabis/marijuana and hemp news and investing content now includes our daily potcastsCM ; podcasts featuring cannabis news and stocks to watch plus insight from thought leaders and experts. Recent interviews include Montel Williams, The Arcview Group, Electrum Partners and the CEO of Cronos Group Inc. (NASDAQ: CRON).



The cannabis stocks potcast (podcast) is also released with an accompanying written transcript. Learn more and sign up at http://www.investorideas.com/Audio/Potcasts.aspOr www.potcasts.ca

To sponsor our daily podcast for the month or to be an expert guest please contact us!

This week’s new Marijuana/Cannabis Stocks Added to the Investor cannabis stock directory:

Chemesis International Inc. (CSE:CSI) is a licensed producer and manufacturer of medical and recreational cannabis in California and Puerto Rico, currently operating a 20,000 square foot, expandable state of the art manufacturing facility in Cathedral City, California and a 120,000 square foot cultivation and manufacturing facility in Puerto Rico. Chemesis International Inc. seeks to be an active participant in the U.S. and international cannabis markets.

Inner Spirit Holdings Ltd. (CSE:ISH) is establishing a chain of recreational cannabis dispensaries under its Spiritleaf brand. Supporting local entrepreneurs by applying its award-winning franchise and retail models, Inner Spirit has more than 100 partnerships in place for Spiritleaf locations across BC, Alberta and Saskatchewan. Inner Spirit will also operate multiple corporate dispensaries. With a diverse portfolio of quality and curated lifestyle cannabis products - including Spiritleaf's own locally and sustainably sourced lines – Inner Spirit's Spiritleaf is positioned to be an iconic Canadian brand and the most trusted source for recreational cannabis

Tilray (NasdaqGS:TLRY) is a global pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids. Tilray was the first licensed producer of medical cannabis in the world to have its facility Good Manufacturing Practices (GMP) certified in accordance with European Medicine Agency (EMA) standards

The complete marijuana/hemp stock list available for purchase in a PDF format:

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the Stock Guru daily podcast on Support and Resistance Trading.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer and disclosure info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas

To sponsor one of our podcasts or columns or be a guest call us today!

Contact Investorideas.com
800-665-0411












Thursday, August 2, 2018

Investorideas.com - #Cannabisstocks: Tilray® (NASDAQ: $TLRY) 2:100 Product Shows Promise in Canada's First Pediatric Study of Mixed THC/CBD Medical Cannabis Oil for Children with Drug-Resistant Epilepsy

Investorideas.com - #Cannabisstocks: Tilray® (NASDAQ: $TLRY) 2:100 Product Shows Promise in Canada's First Pediatric Study of Mixed THC/CBD Medical Cannabis Oil for Children with Drug-Resistant Epilepsy

#Cannabisstocks - ALGAE DYNAMICS CORP (OTC: $ADYNF) SECURES BULK #CANNABIS SUPPLY AGREEMENT FOR COLLABORATION PARTNERS


#Cannabisstocks - ALGAE DYNAMICS CORP (OTC: $ADYNF) SECURES BULK #CANNABIS SUPPLY AGREEMENT FOR COLLABORATION PARTNERS


TORONTO, Aug. 02, 2018 –(Investorideas.com Newswire)  ALGAE DYNAMICS CORP (OTC: ADYNF) (the "Company"), a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, has secured a supply agreement to enable Canadian Licensed Producers and International  Licensed Importers access to bulk cannabis deliveries in anticipation of licensing agreements for our proprietary Cannabis formulated products.


Recent Developments in our Collaboration with Western University
The researchers at Western University, the Company’s scientific collaboration team, have developed a very unique formulation involving cannabis and other botanical extracts. Western University’s Dr. Laviolette said, “We are pleased to report significant progress on our ongoing projects with Algae Dynamics. We are continuing to work out the precise molecular mechanisms underlying the therapeutic modes of action for several unique cannabinoid formulations. These research projects are identifying safer and clinically superior cannabinoid formulations aimed at treating the symptoms of various psychiatric disorders, while eliminating the negative side effects associated with traditional marijuana formats.”

The invention will be assigned to Algae Dynamics Corp. free from any royalties and will become 100% owned by the company.

We are in the process of filing a patent application prior to entering into domestic and international distribution agreements with Licensed Producers/Dealers (LPs/LDs) and Pharmaceutical companies.

Our discussions with the perspective LP’s/LD’s have included the production, distribution and related collaborative initiatives involving our specially formulated products.

We have an assignable supply agreement with a large-volume, high-quality cannabis grower to secure a source of cannabis material for our Licensed Partners producing and selling our Medical Cannabis formulations.

We expect to generate revenue in 2018 from our agreements with our Licensed Partners.
Paul Ramsay stated, “We are pleased that we can further support Dr. Steven Laviolette and his team at Western University by securing a high-quality and high-volume supply of Medical Cannabis for formulations applicable to mental health conditions.”

About Dr. Steven Laviolette
The investigator leading the research is Dr. Steven Laviolette, a Professor and Neuroscientist in the Schulich School of Medicine & Dentistry at Western University in London, Ontario. Dr. Laviolette is a leader in the study of cannabinoids in mental health and was recently awarded “Faculty Scholar” status at Western University. Dr. Laviolette’s research team has previously made numerous fundamental discoveries related to how cannabinoids impact and may serve as treatments for mental health disorders including schizophrenia, depression, post-traumatic stress disorder and anxiety. Dr. Laviolette’s primary research focus is in characterizing how specific phytochemical derivatives of cannabis may interact with specific brain pathways and molecular mechanisms whereby they may improve symptoms associated with various mental health disorders. Research from Dr. Laviolette’s team has been published in the top neuroscience and psychiatry journals in the world. His full profile may be seen on Western University’s, website www.uwo.ca


About Algae Dynamics Corp (ADC)
ADC is engaged in the development of unique health products and nutraceuticals that utilize hemp, cannabis and algae oils. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focused on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health.

For more information, visit http://www.algaedynamics.com

FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds and the development, costs and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.

Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp



Wednesday, August 1, 2018

Investorideas.com - #Cannabisstocks: Sproutly (CSE:SPR) Closes Acquisition of Infusion Biosciences Canada and SSM

Investorideas.com - #Cannabisstocks: Sproutly (CSE:SPR) Closes Acquisition of Infusion Biosciences Canada and SSM

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: Sproutly (CSE:SPR) Closes Acquisition of Infusion Biosciences Canada and SSM

Investorideas.com - #Cannabisstocks: Sproutly (CSE:SPR) Closes Acquisition of Infusion Biosciences Canada and SSM

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: Canopy Growth Corporation (TSX: $WEED.TO, NYSE: $CGC) to Announce First Quarter Fiscal 2019 Financial Results

Investorideas.com - #Cannabisstocks: Canopy Growth Corporation (TSX: $WEED.TO, NYSE: $CGC) to Announce First Quarter Fiscal 2019 Financial Results

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Good #Trading with #Stock Analyst Guru Richard Lazarow - Support and Resistance Trading Podcast Episode 7 - #Cannabis Stocks and #ETF's, #Cybersecurity

Investorideas.com - Good #Trading with #Stock Analyst Guru Richard Lazarow - Support and Resistance Trading Podcast Episode 7 - #Cannabis Stocks and #ETF's, #Cybersecurity